These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11438547)

  • 1. Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages.
    Mukhopadhyay A; Suttles J; Stout RD; Aggarwal BB
    J Biol Chem; 2001 Aug; 276(34):31906-12. PubMed ID: 11438547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of the tumor necrosis factor receptor p60 or p80 sensitizes macrophages to lipopolysaccharide-induced nuclear factor-kappa B, mitogen-activated protein kinases, and apoptosis.
    Takada Y; Aggarwal BB
    J Biol Chem; 2003 Jun; 278(26):23390-7. PubMed ID: 12695514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation.
    Haridas V; Darnay BG; Natarajan K; Heller R; Aggarwal BB
    J Immunol; 1998 Apr; 160(7):3152-62. PubMed ID: 9531270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that genetic deletion of the TNF receptor p60 or p80 in macrophages modulates RANKL-induced signaling.
    Takada Y; Aggarwal BB
    Blood; 2004 Dec; 104(13):4113-21. PubMed ID: 15315973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
    Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL
    Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of the nuclear factor-kappa B by TNF muteins specific for the p60 and p80 TNF receptors.
    Chainy GB; Singh S; Raju U; Aggarwal BB
    J Immunol; 1996 Sep; 157(6):2410-7. PubMed ID: 8805640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.
    Cheng N; Chen J
    J Biol Chem; 2001 Apr; 276(17):13771-7. PubMed ID: 11278471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases.
    Amrani Y; Ammit AJ; Panettieri RA
    Mol Pharmacol; 2001 Oct; 60(4):646-55. PubMed ID: 11562425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics.
    Kalb A; Bluethmann H; Moore MW; Lesslauer W
    J Biol Chem; 1996 Nov; 271(45):28097-104. PubMed ID: 8910423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
    Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
    Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a synergistic role of two types of human tumor necrosis factor receptors for the ligand-dependent activation of the nuclear transcription factor NF-kappaB.
    Mukherjee R; Singh S; Chaturvedi MM; Aggarwal BB
    J Interferon Cytokine Res; 1998 Feb; 18(2):117-23. PubMed ID: 9506462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated apoptosis in macrophages.
    Takada Y; Sung B; Sethi G; Chaturvedi MM; Aggarwal BB
    Biochem Pharmacol; 2007 Oct; 74(7):1057-64. PubMed ID: 17692826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
    Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
    Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
    Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
    J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis.
    Ahn KS; Sethi G; Jain AK; Jaiswal AK; Aggarwal BB
    J Biol Chem; 2006 Jul; 281(29):19798-808. PubMed ID: 16682409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
    Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
    J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.
    Marchetti L; Klein M; Schlett K; Pfizenmaier K; Eisel UL
    J Biol Chem; 2004 Jul; 279(31):32869-81. PubMed ID: 15155767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.